ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,963,198 | -21.6% | 1,042,395 | -1.5% | 0.04% | -16.3% |
| Q2 2023 | $8,881,200 | -51.5% | 1,058,546 | -42.6% | 0.05% | -54.2% |
| Q1 2023 | $18,311,000 | +48.5% | 1,844,010 | +4.1% | 0.11% | +40.8% |
| Q4 2022 | $12,330,000 | +58.4% | 1,771,689 | +21.5% | 0.08% | +49.0% |
| Q3 2022 | $7,785,000 | +29.6% | 1,458,008 | -3.2% | 0.05% | +34.2% |
| Q2 2022 | $6,008,000 | -8.3% | 1,505,938 | +2.2% | 0.04% | +11.8% |
| Q1 2022 | $6,549,000 | +15.8% | 1,473,459 | +5.8% | 0.03% | +36.0% |
| Q4 2021 | $5,655,000 | -52.2% | 1,392,936 | +3.5% | 0.02% | -52.8% |
| Q3 2021 | $11,821,000 | -3.9% | 1,346,468 | +24.0% | 0.05% | 0.0% |
| Q2 2021 | $12,298,000 | – | 1,085,518 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
| Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
| Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
| Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
| Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
| Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
| Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
| Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
| APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |